StonvexLoading…
StonvexStonvexStonvexCore line items from SSTK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $199.17M | $989.92M | $769.70M | $509.61M |
Operating Income | $-30.95M | $75.06M | $77.42M | $44.93M |
Net Income | $-47.57M | $45.50M | $61.52M | $48.13M |
EPS (Diluted) | $-1.34 | $1.25 | $1.71 | $1.35 |
Total Assets | $1.31B | $1.36B | $1.38B | $1.38B |
Total Liabilities | $779.12M | $774.90M | $781.24M | $790.29M |
Cash & Equivalents | $162.52M | $178.24M | $165.54M | $116.41M |
Free Cash Flow OCF − CapEx | $5.78M | $123.83M | $97.93M | $29.96M |
Shares Outstanding | 35.55M | 35.53M | 35.50M | 35.29M |